PARK, Ki Sook,KIM, Sung Won,KIM, Ji Yoon,YOO, Seok Cheol,KIM, Ri Sun,AHN, Jae Soon,YOON, Hye Jin,JUNG, Jong Hyuk
申请号：
PE2019001004
公开号：
PE20191502A1
申请日:
2017.11.15
申请国别(地区):
PE
年份:
2019
代理人:
摘要：
The present invention refers to a mixture, including Gemini fat, which is an inhibitor of foam four, or a salt acceptable from pharmacology, and rosuvastatina, which is an inhibitor of reducing HMG-CoA or a salt acceptable from pharmacology. In addition, it may also include stabilizers, polymers, splitters, gliding agents, freight forwarders, etc., as acceptable pre prescriptions. This kind of training is helpful for the effective treatment of type 2 diabetes mellitus and debinding disease of diabetic patients.La presente invencion se refiere a una combinacion que comprende gemigliptina, que es un inhibidor de peptidasa IV o una sal farmaceuticamente aceptable del mismo, y rosuvastatina, que es un inhibidor de la HMG-CoA reductasa o una sal farmaceuticamente aceptable del mismo. Ademas, puede comprender estabilizadores, aglutinantes, desintegrantes, deslizantes, agentes de carga y similares como excipientes farmaceuticamente aceptables. Dicha preparacion sirve para tratar eficazmente la diabetes mellitus tipo 2 y la dislipidemia en pacientes diabeticos.
